Net Income (Loss) Attributable to Parent in USD of Gossamer Bio, Inc. from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Gossamer Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to Q3 2025.
  • Gossamer Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2025 was -$48.2M, a 56.5% decline year-over-year.
  • Gossamer Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2025 was -$156M, a 118% decline year-over-year.
  • Gossamer Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$56.5M, a 68.6% increase from 2023.
  • Gossamer Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$180M, a 21.6% increase from 2022.
  • Gossamer Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$229M, a 1.98% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)

Gossamer Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$156M -$48.2M -$17.4M -56.5% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 -$139M -$38.3M -$87.5M -178% Apr 1, 2025 Jun 30, 2025 10-Q 2025-11-05
Q1 2025 -$51.2M -$36.6M +$5.29M +12.6% Jan 1, 2025 Mar 31, 2025 10-Q 2025-11-05
Q4 2024 -$56.5M -$33M +$15.1M +31.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 -$71.6M -$30.8M +$9.21M +23% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
Q2 2024 -$80.9M $49.2M +$91.7M Apr 1, 2024 Jun 30, 2024 10-Q 2025-11-05
Q1 2024 -$173M -$41.9M +$7.24M +14.7% Jan 1, 2024 Mar 31, 2024 10-Q 2025-11-05
Q4 2023 -$180M -$48.1M +$7.62M +13.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 -$187M -$40M +$19.4M +32.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$207M -$42.5M +$14M +24.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$221M -$49.2M +$8.62M +14.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$229M -$55.8M +$520K +0.92% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-13
Q3 2022 -$230M -$59.4M +$884K +1.47% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$231M -$56.5M +$3.37M +5.63% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$234M -$57.8M -$144K -0.25% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$234M -$56.3M +$8.32M +12.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$242M -$60.2M -$2.44M -4.21% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$240M -$59.8M +$7.04M +10.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$247M -$57.6M -$3.57M -6.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$243M -$64.6M -$9.91M -18.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-17
Q3 2020 -$233M -$57.8M -$9.31M -19.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$224M -$66.9M -$22.4M -50.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-08
Q1 2020 -$202M -$54.1M -$21.5M -65.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-08
Q4 2019 -$180M -$54.7M -$15.9M -41% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-24
Q3 2019 -$164M -$48.5M +$909K +1.84% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$165M -$44.5M -$11.8M -36% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$154M -$32.6M -$6.57M -25.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-10
Q4 2018 -$147M -$38.8M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$49.4M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-24
Q2 2018 -$32.7M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-24
Q1 2018 -$26M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-24

Gossamer Bio, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$56.5M +$123M +68.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 -$180M +$49.6M +21.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 -$229M +$4.63M +1.98% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-13
2021 -$234M +$9.36M +3.85% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 -$243M -$63.1M -35% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-17
2019 -$180M -$33.3M -22.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-03
2018 -$147M -$140M -2071% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$6.77M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.